9to5Mac filed a legal filing saw That said, Apple lawyers have proposed a solution to completely turn off the blood oxygen saturation (SpO2) monitoring – or pulse oximetry – feature on the company’s latest Apple Watch Series 9 and Watch Ultra 2 models. The features could be disabled in the future to circumvent a ban imposed by the ITC last year on imports of the latest smartwatches into the US for infringing two patents of health device maker Masimo.
According to the report, disabling the pulse oximetry feature on the Apple Watch Series 9 and Watch Ultra 2 will mean that the products will no longer infringe the firm’s patents. These features also will not affect existing owners in the US or all owners outside the country. The ITC ordered a ban on the import of two smartwatch models into the US after deciding that the Cupertino company’s products infringe Masimo’s patent related to the pulse oximetry feature.
Meanwhile, Apple told the publication that until the US Court of Appeals decides to stay the import ban during the ITC’s appeal period, Apple will continue to offer support for pulse oximetry on the Apple Watch 9 and Watch Ultra 2. The ITC opposed Apple’s motion for a stay on the import ban, saying the company did not suffer ‘irreparable injury’ from the ban as sales of only a few models were affected.
Apple put both smartwatch models on sale again in the US late last month. Let us tell you that after the ban on the sale of these models, they will be launched on 21st December. removed from sale I went.